Clinical Trial Update: Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HS-25 with atorvastatin in patients with hypercholesterolemia in coronary heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia in Coronary Heart Disease

Drugs mentioned

• HS-25
• atorvastatin (atorvastatin)

Snippet

Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. | Conditions: Hypercholesterolemia in Coronaory Heart Disease | Phase 3 | Status: COMPLETED